Quarterly report [Sections 13 or 15(d)]

Note 7 - Net Income (Loss) Per Share - Basic and Diluted Loss Per Share (Details)

v3.26.1
Note 7 - Net Income (Loss) Per Share - Basic and Diluted Loss Per Share (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Net income (loss) $ (5,313,300) $ (3,893,050) $ (2,453,526) $ (2,624,972) $ (9,206,350) $ (5,078,498)
Weighted Average Number of Shares Outstanding, Basic (in shares) [1] 8,542,450   6,998,082   8,538,966 6,992,761
Net income (loss) per common share, basic and diluted (in dollars per share) $ (0.62)   $ (0.35)   $ (1.08) $ (0.73)
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)         823,127 754,939
Share-Based Payment Arrangement, Option [Member]            
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) 678,000   627,000   678,000 627,000
Restricted Stock Units (RSUs) [Member]            
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) 145,000   128,000   145,000 128,000
[1] Pre-funded warrants outstanding during the three and six months ended June 30, 2026 and 2025, are exercisable at a nominal price and are considered, in substance, equivalent to outstanding common stock. Accordingly, such pre-funded warrants have been included in the calculation of weighted-average shares of common stock outstanding for purposes of basic and diluted net income (loss) per share.